Search / Trial NCT06232161

Sustained Effect of Red-light Therapy for Myopia Control: A 2-Year Post-Trial Follow-up Study

Launched by BEIJING AIRDOC TECHNOLOGY CO., LTD. · Jan 20, 2024

Trial Information

Current as of October 07, 2024

Unknown status

Keywords

Myopia, Red Light Therapy

Description

Interventions and visits All spectacle lenses were made for single focus with full correction for each subject as the first intervention throughout the whole procedure for both groups. PBM therapy was performed with a low-intensity laser (LD-A, Jilin LD Optoelectronics Technology, Jilin, China) with an irradiance of 0.35 ± 0.02 mW/cm2, a wavelength of 650 nm ± 10 nm, and illumination of approximately 400 lux on average at the first 12 month. At the second 12 months, non-randomized cohorts continued according to the willing to use the device from both groups. Once decided, those usage would ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Clinical diagnosis of myopia;
  • 2. Ages of 9\~13 years old;
  • 3. Must be with best corrected visual acuity ≥20/25 (decimal record);
  • 4. Must be the subject in the previous study of 12-month red-light therapy of myopia;
  • Exclusion Criteria:
  • 1. Clinical diagnosis of glaucoma or retinal lesions;
  • 2. Clinical diagnosis of optic media lesions (e.g., central thick corneal scars, cataract);
  • 3. Clinical diagnosis of optic nerve dysfunction;
  • 4. Clinical diagnosis of amblyopia;
  • 5. Must be eligible for follow-up.

About Beijing Airdoc Technology Co., Ltd.

Beijing Airdoc Technology Co., Ltd. is a leading innovator in the field of medical technology, specializing in the development of advanced diagnostic solutions powered by artificial intelligence. With a commitment to enhancing healthcare outcomes, the company focuses on creating non-invasive screening tools that facilitate early disease detection and management. Airdoc's proprietary technologies aim to streamline clinical workflows and improve patient accessibility to vital health services, positioning the company at the forefront of the digital health revolution. Through robust research and clinical trials, Beijing Airdoc Technology is dedicated to transforming the landscape of medical diagnostics and contributing to the global healthcare ecosystem.

Locations

Ningbo, Zhejiang, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0